top of page
Funded Projects
Ruthenium-peptide conjugates:
arrows for selectively targeting breast cancer
Arrows2cancer
Arrows2cancer mission is to develop an innovative and precise chemotherapeutic for triple negative breast cancer.
PTDC/QUI-QIN/0146/2020
Funding: € 249.9k
bottom of page